FDA uncertain about risk from abortion pill

05/17/2006 | Mercury News (San Jose, Calif.), The

FDA Deputy Commissioner Janet Woodcock told a congressional panel the FDA does not know if the abortion pill increases the risk of an infection that killed four women. Woodcock's testimony was given at a hearing urged by opponents of the RU-486 drug who suggest it is dangerous to women and should be banned.

View Full Article in:

Mercury News (San Jose, Calif.), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD